Isomorphic Labs

Isomorphic Labs is a drug discovery company launched in the United Kingdom in November 2021.

The company was established under [1] Alphabet Inc., the parent company of Google.[2] It is led by Demis Hassabis.[2] Isomorphic Labs was incorporated in February 2021 and announced on November 5, 2021.[1]

Isomorphic Labs uses artificial intelligence for drug discovery.[3][4][5]

References
  1. Shead, Sam. "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Retrieved August 4, 2022.
  2. Coldewey, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery". TechCrunch. Retrieved August 23, 2022.
  3. Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Archived from the original on November 5, 2021. Retrieved November 9, 2021.
  4. Crist, Ry (November 4, 2021). "Alphabet launches Isomorphic Labs, an AI-driven drug discovery startup". CNET.
  5. Coldeway, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery". TechCrunch.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.